Many studies have documented the negative effects of depression on adherence to recommended treatment; however, little is known about the mechanism underlying this relationship. Using the Kenny and Baron analytic framework of mediation, the authors assessed whether self-efficacy mediated the relationship between depression and medication adherence in 167 hypertensive African Americans followed in a primary care practice. Depressive symptoms are associated with poor medication adherence (β = .013, p = .036) and low self-efficacy (β = —.008, p = .023). Self-efficacy is negatively associated with medication adherence at follow-up (β = —.612, p < .001). The relationship between depressive symptoms and medication adherence becomes nonsignificant when controlling for self-efficacy (β = .010, p = .087). Implications for further examination into the mediating role of self-efficacy and the deleterious effect of depression on medication adherence are discussed.
Allegrante, J.P., & Marks, R. (2003). Self-efficacy in management of osteoarthritis . Rheumatic Disease Clinics of North America, 29(4), 747-768.
2.
Arnstein, P. (2000). The mediation of disability by self efficacy in different samples of chronic pain patients. Disability and Rehabilitation, 22(17), 794-801.
3.
Aroian, L.A. (1947). The probability function of the product of two normally distributed variables. Annals of Mathematical Statistics , 18, 265-270.
4.
Bandura, A. (1977). Self-efficacy: Toward a unifying theory of behavioral change. Psychological Review, 84(2), 191-215.
5.
Baron, R.M., & Kenny, D.A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations . Journal of Personality and Social Psychology, 51(6), 1173-1182.
6.
Beck, A.T. (1967). Depression: Clinical, experimental, and theoretical aspects. New York: Hoeber Medical Division.
7.
Bertakis, K.D., Helms, L.J., Callahan, E.J., Azari, R., Leigh, P., & Robbins, J.A. (2001). Patient gender differences in the diagnosis of depression in primary care. Journal of Women's Health and Gender Based Medicine, 10(7), 689-698.
8.
Bosworth, H.B., Dudley, T., Olsen, M.K., Voils, C.I., Powers, B., Goldstein, M.K., et al. (2006). Racial differences in blood pressure control: Potential explanatory factors. American Journal of Medicine , 119(1), e79-e115.
9.
Brus, H., van de Laar, M., Taal, E., Rasker, J., & Wiegman, O. (1999). Determinants of compliance with medication in patients with rheumatoid arthritis: The importance of self-efficacy expectations . Patient Education and Counseling, 36(1), 57-64.
10.
Charlson, M.E., Pompei, P., Ales, K.L., & MacKenzie, C.R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation . Journal of Chronic Disease, 40(5), 373-383.
11.
Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L., Jr., et al. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. Journal of the American Medical Association, 289(19), 2560-2572.
12.
Ciechanowski, P.S., Katon, W.J., & Russo, J.E. (2000). Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Archives of Internal Medicine, 160(21), 3278-3285.
13.
Cinciripini, P.M., Wetter, D.W., Fouladi, R.T., Blalock, J.A., Carter, B.L., Cinciripini, L.G., et al. (2003). The effects of depressed mood on smoking cessation: Mediation by postcessation self-efficacy. Journal of Consulting and Clinical Psychology, 71(2), 292-301.
14.
Clark, N.M., & Dodge, J.A. (1999). Exploring self-efficacy as a predictor of disease management. Health Education and Behavior, 26(1), 72-89.
15.
Farmer, M.E., Locke, B.Z., Moscicki, E.K., Dannenberg, A.L., Larson, D.B., & Radloff, L.S. (1988). Physical activity and depressive symptoms: The NHANES I Epidemiologic Follow-up Study. American Journal of Epidemiology, 128(6), 1340-1351.
16.
Hertz, R.P., Unger, A.N., Cornell, J.A., & Saunders, E. (2005). Racial disparities in hypertension prevalence, awareness, and management. Archives of Internal Medicine, 165(18), 2098-2104.
17.
Katz, R.C., Ashmore, J., Barboa, E., Trueblood, K., McLaughlin, V., & Mathews, L. (1998). Knowledge of disease and dietary compliance in patients with end-stage renal disease. Psychological Reports , 82(1), 331-336.
18.
Kim, M.T., Han, H.R., Hill, M.N., Rose, L., & Roary, M. (2003). Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive Black men. Annals of Behavioral Medicine, 26(1), 24-31.
19.
Kobau, R., & DiIorio, C. (2003). Epilepsy self-management: A comparison of self-efficacy and outcome expectancy for medication adherence and lifestyle behaviors among people with epilepsy. Epilepsy Behavior, 4(3), 217-225.
20.
MacKinnon, D.P., Warsi, G., & Dwyer, J.H. (1995a). A simulation study of mediated effect measures . Multivariate Behavioral Research, 30(1), 41-62.
21.
MacKinnon, D.P., Waris, G., & Dwyer, J.H. (1995b). "A simulation study of mediated effect measures ": Erratum. Multivariate Behavioral Research, 30(3), ii.
22.
Morisky, D.E., Green, L.W., & Levine, D.M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67-74.
23.
Neutel, J.M., & Smith, D.H. (2003). Improving patient compliance: A major goal in the management of hypertension. Journal of Clinical Hypertension (Greenwich), 5(2), 127-132.
24.
Ogedegbe, G., Mancuso, C.A., Allegrante, J.P., & Charlson, M.E. (2003). Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. Journal of Clinical Epidemiology, 56(6), 520-529.
25.
Ogedegbe, G., Schoenthaler, A., Richardson, T., Lewis, L., Belue, R., Espinosa, E., et al. (2007). An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: Rationale and design . Contemporary Clinical Trials, 28(2), 169-181.
26.
O'Leary, A. (1985). Self-efficacy and health. Behavioral Research and Therapy, 23(4), 437-451.
27.
Ong, K.L., Cheung, B.M., Man, Y.B., Lau, C.P., & Lam, K.S. (2007). Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension , 49(1), 69-75.
28.
Rose, L.E., Kim, M.T., Dennison, C.R., & Hill, M.N. (2000). The contexts of adherence for African Americans with high blood pressure. Journal of Advanced Nursing, 32(3), 587-594.
29.
Sacco, W.P., Wells, K.J., Vaughan, C.A., Friedman, A., Perez, S., & Matthew, R. (2005). Depression in adults with Type 2 diabetes: The role of adherence, body mass index, and self-efficacy. Health Psychology, 24(6), 630-634.
30.
Shea, S., Misra, D., Ehrlich, M.H., Field, L., & Francis, C.K. (1992). Correlates of nonadherence to hypertension treatment in an inner-city minority population. American Journal of Public Health, 82(12), 1607-1612.
31.
Sobel, M. (1982). Asymptotic intervals for indirect effects in structural equations models. In S. Leinhart (Ed.), Sociological methodology (pp. 290-312). San Francisco : Jossey-Bass.
32.
Sowers, J.R., Ferdinand, K.C., Bakris, G.L., & Douglas, J.G. (2002). Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcome. Postgraduate Medicine, 112(4), 24-26, 29-30, 33-34.
33.
Wang, P.S., Avorn, J., Brookhart, M.A., Mogun, H., Schneeweiss, S., Fischer, M.A., et al. (2005). Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension , 46(2), 273-279.
34.
Wang, P.S., Bohn, R.L., Knight, E., Glynn, R.J., Mogun, H., & Avorn, J. (2002). Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors. Journal of General Internal Medicine, 17(7), 504-511.
35.
Wing, R.R., Phelan, S., & Tate, D. (2002). The role of adherence in mediating the relationship between depression and health outcomes. Journal of Psychosomatic Research, 53(4), 877-881.
36.
Wong, M.D., Shapiro, M.F., Boscardin, W.J., & Ettner, S.L. (2002). Contribution of major diseases to disparities in mortality. New England Journal of Medicine, 347(20), 1585-1592.
37.
World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. Geneva, Switzerland: World Health Organization.
